NYSE American - Nasdaq Real Time Price USD
Theriva Biologics, Inc. (TOVX)
0.6432
-0.1668
(-20.59%)
At close: May 8 at 4:00:00 PM EDT
0.6355
-0.01
(-1.20%)
After hours: May 8 at 7:59:35 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-16,937
-16,937
-18,996
-19,082
-12,890
Investing Cash Flow
-1
-1
-202
-4,396
-14
Financing Cash Flow
5,496
5,496
625
-1,930
74,002
End Cash Position
11,705
11,705
23,279
41,885
67,325
Capital Expenditure
-1
-1
-202
-116
-14
Issuance of Capital Stock
5,563
5,563
2,219
2,734
65,960
Repayment of Debt
-67
-67
-75
-1,376
0
Repurchase of Capital Stock
--
--
0
-288
0
Free Cash Flow
-16,938
-16,938
-19,198
-19,198
-12,904
12/31/2021 - 12/18/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KTTA Pasithea Therapeutics Corp.
0.9600
-15.04%
ZVSA ZyVersa Therapeutics, Inc.
0.5712
-16.59%
CAMP CAMP4 THERAPEUTICS CORPORATION
2.1400
-2.28%
NCNA NuCana plc
0.1029
-65.83%
GLMD Galmed Pharmaceuticals Ltd.
1.2500
-3.10%
ADIL Adial Pharmaceuticals, Inc.
0.6200
-4.85%
IBO Impact BioMedical Inc.
0.4975
-2.49%
SPRC SciSparc Ltd.
0.3500
+12.90%
PLRZ Polyrizon Ltd.
0.5908
-9.59%
PHIO Phio Pharmaceuticals Corp.
1.8000
-11.76%